Earlier this week, Biogen announced the results of their VALOR study, which evaluated the use of an antisense drug called tofersen to treat MND caused by the genetic mutation SOD1...
We've just launched our new 2021–2022 strategy. As always, our vision remains — A world free of MND ...
The September edition of MND Australia's International Research Update is available to read online. Catch up on the latest on ...
$43M
invested in research to find treatments and a cure for motor neurone disease
2,100
Australians currently living with MND who we support through investment in research, care and advocacy
148
evidence-based MND information materials developed to advance care and quality of life
